High Dose of Intravenous Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells (CLV-100) Infusion Displays Better Immunomodulatory Effect Among Healthy Volunteers: A Phase 1 Clinical Study

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2020 Oct 16

PMID 33061992

Citations 10

Authors

Sze-Piaw Chin

Mohd-Yusoff Mohd-Shahrizal

Mohd-Zuhar Liyana

Kong Yong Then

Soon Keng Cheong

Affiliations

Soon will be listed here.

Abstract

Background: Mesenchymal stem cells (MSCs) express growth factors and other cytokines that stimulate repair and control the immune response. MSCs are also immunoprivileged with low risk of rejection. Umbilical cord-derived MSCs (UCMSCs) are particularly attractive as an off-the-shelf allogeneic treatment in emergency medical conditions. We aim to determine the safety and efficacy of intravenous allogeneic infusion of UCMSCs (CLV-100) by Cytopeutics® (Selangor, Malaysia) in healthy volunteers, and to determine the effective dose at which an immunomodulatory effect is observed. . Umbilical cord samples were collected after delivery of full-term, healthy babies with written consent from both parents. All 3 generations (newborn, parents, and grandparents) were screened for genetic mutations, infections, cancers, and other inherited diseases. Samples were transferred to a certified Good Manufacturing Practice laboratory for processing. Subjects were infused with either low dose (LD, 65 million cells) or high dose (HD, 130 million cells) of CLV-100 and followed up for 6 months. We measured cytokines using ELISA including anti-inflammatory cytokines interleukin 1 receptor antagonist (IL-1RA), interleukin 10 (IL-10), pro-/anti-inflammatory cytokine interleukin 6 (IL-6), and the proinflammatory cytokine tumor necrosis factor-alpha (TNF-).

Results: 11 healthy subjects (LD, = 5; HD, = 6; mean age of 55 ± 13 years) were recruited. All subjects tolerated the CLV-100 infusion well with no adverse reaction throughout the study especially in vital parameters and routine blood tests. At 6 months, the HD group had significantly higher levels of anti-inflammatory markers IL1-RA (705 ± 160 vs. 306 ± 36 pg/mL; = 0.02) and IL-10 (321 ± 27 vs. 251 ± 28 pg/mL; = 0.02); and lower levels of proinflammatory marker TNF- (74 ± 23 vs. 115 ± 15 pg/mL; = 0.04) compared to LD group.

Conclusion: Allogeneic UCMSCs CLV-100 infusion is safe and well-tolerated in low and high doses. Anti-inflammatory effect is observed with a high-dose infusion.

Citing Articles

The Impact of Umbilical Cord Mesenchymal Stem Cells on Motor Function in Children with Cerebral Palsy: Results of a Real-world, Compassionate use Study.

Chroscinska-Kawczyk M, Zdolinska-Malinowska I, Boruczkowski D Stem Cell Rev Rep. 2024; 20(6):1636-1649.

PMID: 38877284 DOI: 10.1007/s12015-024-10742-2.

A case series on safety and tolerability of human umbilical cord-derived mesenchymal stem cells on patients in Malaysia.

Yusof B, Kamal I, Lee K, Chai S, Zuo X, Ravichandran M SAGE Open Med Case Rep. 2024; 12:2050313X241249622.

PMID: 38694904 PMC: 11062224. DOI: 10.1177/2050313X241249622.

Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells.

Chin S, Saffery N, Then K, Cheong S In Vitro Cell Dev Biol Anim. 2024; 60(3):307-319.

PMID: 38421574 PMC: 11014873. DOI: 10.1007/s11626-024-00852-z.

Dynamic tracking of human umbilical cord mesenchymal stem cells (hUC-MSCs) following intravenous administration in mice model.

Chin S, Marzuki M, Tai L, Mohamed Shahrehan N, Ricky C, Fanty A Regen Ther. 2024; 25:273-283.

PMID: 38314402 PMC: 10834363. DOI: 10.1016/j.reth.2024.01.003.

[A prospective study on application of human umbilical cord mesenchymal stem cells combined with autologous Meek microskin transplantation in patients with extensive burns].

Yan T, Xiao R, Wang Y, Lin G, Zheng Y, Zhao H Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023; 39(2):114-121.

PMID: 36878520 PMC: 11630450. DOI: 10.3760/cma.j.cn501225-20220728-00319.

References

Troen B . The biology of aging. Mt Sinai J Med. 2003; 70(1):3-22. View

Nauta A, Fibbe W . Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007; 110(10):3499-506. DOI: 10.1182/blood-2007-02-069716. View

Wu K, Chan C, Tsai C, Chang Y, Sieber M, Chiu T . Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation. 2011; 91(12):1412-6. DOI: 10.1097/TP.0b013e31821aba18. View

Jiang Y, Jahagirdar B, Reinhardt R, Schwartz R, Keene C, Ortiz-Gonzalez X . Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418(6893):41-9. DOI: 10.1038/nature00870. View

Chin S, Poey A, Wong C, Chang S, Teh W, Mohr T . Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy. Cytotherapy. 2009; 12(1):31-7. DOI: 10.3109/14653240903313966. View

Golpanian S, DiFede D, Khan A, Schulman I, Landin A, Tompkins B . Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty. J Gerontol A Biol Sci Med Sci. 2017; 72(11):1505-1512. PMC: 5861970. DOI: 10.1093/gerona/glx056. View

Luna J, Moon Y, Liu K, Spitalnik S, Paik M, Cheung K . High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study. Stroke. 2014; 45(4):979-87. PMC: 4048752. DOI: 10.1161/STROKEAHA.113.002289. View

Choong P, Mok P, Cheong S, Leong C, Then K . Generating neuron-like cells from BM-derived mesenchymal stromal cells in vitro. Cytotherapy. 2007; 9(2):170-83. DOI: 10.1080/14653240701196829. View

Kong D, Wang H, Liu Y, Li H, Wang H, Zhu P . Correlation between the expression of inflammatory cytokines IL-6, TNF-α and hs-CRP and unfavorable fetal outcomes in patients with pregnancy-induced hypertension. Exp Ther Med. 2018; 16(3):1982-1986. PMC: 6122102. DOI: 10.3892/etm.2018.6393. View

10.

Togel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C . Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol. 2007; 292(5):F1626-35. DOI: 10.1152/ajprenal.00339.2006. View

11.

Koyama T, Kuriyama N, Ozaki E, Matsui D, Watanabe I, Miyatani F . Serum albumin to globulin ratio is related to cognitive decline via reflection of homeostasis: a nested case-control study. BMC Neurol. 2016; 16(1):253. PMC: 5146886. DOI: 10.1186/s12883-016-0776-z. View

12.

Kim H, Lee J, Roh K, Jun H, Kang K, Kim T . Clinical Trial of Human Umbilical Cord Blood-Derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies. Stem Cells. 2016; 35(1):248-255. DOI: 10.1002/stem.2401. View

13.

Meng M, Liu Y, Wang W, Wei C, Liu F, Du Z . Umbilical cord mesenchymal stem cell transplantation in the treatment of multiple sclerosis. Am J Transl Res. 2018; 10(1):212-223. PMC: 5801359. View

14.

Wang S, Hu S, Zhang Q, Xia A, Jiang Z, Chen X . Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties. PLoS One. 2015; 10(8):e0136026. PMC: 4546153. DOI: 10.1371/journal.pone.0136026. View

15.

Suh B, Park S, Shin D, Yun J, Keam B, Yang H . Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol. 2014; 25(11):2260-2266. DOI: 10.1093/annonc/mdu274. View

16.

Li J, Yin H, Shuboy A, Duan H, Lou J, Li J . Differentiation of hUC-MSC into dopaminergic-like cells after transduction with hepatocyte growth factor. Mol Cell Biochem. 2013; 381(1-2):183-90. DOI: 10.1007/s11010-013-1701-z. View

17.

Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E, Laakso M . Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome. Mediators Inflamm. 2008; 2007:93573. PMC: 2222666. DOI: 10.1155/2007/93573. View

18.

Keller C, Gonwa T, Hodge D, Hei D, Centanni J, Zubair A . Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction. Stem Cells Transl Med. 2018; 7(2):161-167. PMC: 5788872. DOI: 10.1002/sctm.17-0198. View

19.

Ali E, Jabbar A, Mohammed A . A Comparative Study of Interleukin 6, Inflammatory Markers, Ferritin, and Hematological Profile in Rheumatoid Arthritis Patients with Anemia of Chronic Disease and Iron Deficiency Anemia. Anemia. 2019; 2019:3457347. PMC: 6463678. DOI: 10.1155/2019/3457347. View

20.

Kablak-Ziembicka A, Przewlocki T, Stepien E, Pieniazek P, Rzeznik D, Sliwiak D . Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis. Kardiol Pol. 2011; 69(10):1024-31. View